CATX Perspective Therapeutics, Inc.
NYSE · SEC CIK 728387 · EDGAR
- Bought, last 12 months
- $42.3K 2 purchases by 2 insiders
- Sold, last 12 months
- $1.62M 5 sales by 2 insiders
- Filings on record
- 100 since 2021-07-06, latest 2026-09-08 16:51
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Lantheus Alpha Therapy, LLC | 10% | — | $1.27M |
| Lantheus Holdings, Inc. | 10% | — | $357.2K |
| Hunt Jonathan Robert | CAO | $22.3K | — |
| Williamson Robert F III | Dir | $19.9K | — |
Transactions 46
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-08 16:51 | 2026-09-03+ | CATX | Lantheus Alpha Therapy, LLC | 10% | S - Sale | $3.13 | -247.9K | 11.27M | -2% | -$776.9K |
| 2026-09-04 17:00 | 2026-09-02 | CATX | Lantheus Alpha Therapy, LLC | 10% | S - Sale | $3.11 | -42.1K | 11.52M | -0.4% | -$131.2K | |
| M | 2026-09-04 16:58 | 2026-08-31+ | CATX | Lantheus Alpha Therapy, LLC | 10% | S - Sale | $3.14 | -113.9K | 11.56M | -1.0% | -$357.2K |
| 2026-09-03 16:54 | 2026-09-01 | CATX | Lantheus Holdings, Inc. | 10% | S - Sale | $3.12 | -35.8K | 11.56M | -0.3% | -$111.6K | |
| 2026-09-02 16:36 | 2026-08-31 | CATX | Lantheus Holdings, Inc. | 10% | S - Sale | $3.14 | -78.1K | 11.60M | -0.7% | -$245.6K | |
| 2025-11-17 | 2025-11-13 | CATX | Hunt Jonathan Robert | CAO | P - Purchase | $2.03 | +11.0K | 59.8K | +23% | +$22.3K | |
| I | 2025-11-14 | 2025-11-12 | CATX | Williamson Robert F III | Dir | P - Purchase | $2.10 | +9,498 | 9,864 | +2,595% | +$19.9K |
| I | 2025-04-01 | 2025-03-28 | CATX | Spoor Johan M. | CEO, Dir | P - Purchase | $2.21 | +4,650 | 4,650 | New | +$10.3K |
| 2025-04-01 | 2025-03-28 | CATX | Spoor Johan M. | CEO, Dir | P - Purchase | $2.24 | +22.0K | 59.4K | +59% | +$49.3K | |
| M | 2025-04-01 | 2025-03-28+ | CATX | Williamson Robert F III | Dir | P - Purchase | $2.19 | +60.3K | 70.8K | +575% | +$132.0K |
| 2025-04-01 | 2025-03-28 | CATX | Graham Juan | CFO | P - Purchase | $2.25 | +33.3K | 35.4K | +1,649% | +$75.0K | |
| I | 2025-04-01 | 2025-03-31 | CATX | Woods Lori A | Dir | P - Purchase | $2.13 | +23.5K | 183.5K | +15% | +$50.0K |
| I | 2024-12-06 | 2024-12-04 | CATX | HENSON HEIDI | Dir | P - Purchase | $3.85 | +26.0K | 26.0K | New | +$100.0K |
| 2024-12-04 | 2024-12-04 | CATX | Spoor Johan M. | CEO, Dir | P - Purchase | $3.77 | +8,000 | 36.3K | +28% | +$30.2K | |
| M | 2024-11-27 | 2024-11-25 | CATX | Williamson Robert F III | Dir | P - Purchase | $3.64 | +6,266 | 430.1K | +1% | +$22.8K |
| M | 2024-11-27 | 2024-11-25 | CATX | Hunt Jonathan Robert | CFO | P - Purchase | $3.82 | +12.8K | 36.4K | +54% | +$49.0K |
| MI | 2024-11-26 | 2024-11-25 | CATX | Spoor Johan M. | CEO, Dir | P - Purchase | $3.80 | +12.0K | 5,400 | New | +$45.6K |
| 2024-11-26 | 2024-11-25 | CATX | Spoor Johan M. | CEO, Dir | P - Purchase | $3.78 | +14.5K | 152.1K | +11% | +$54.8K | |
| MI | 2024-06-18 | 2024-06-14 | CATX | Woods Lori A | Dir | P - Purchase | $10.90 | +4,587 | 160.0K | +3% | +$50.0K |
| 2024-06-18 | 2024-06-17 | CATX | Hunt Jonathan Robert | CFO | P - Purchase | $9.82 | +1,800 | 36.0K | +5% | +$17.7K | |
| 2024-06-13 | 2024-06-13 | CATX | Spoor Johan M. | CEO, Dir | P - Purchase | $1.17 | +100.0K | 137.6K | +266% | +$117.0K | |
| I | 2024-06-04 | 2024-06-03 | CATX | Woods Lori A | Dir | P - Purchase | $1.46 | +34.2K | 1.55M | +2% | +$50.0K |
| M | 2024-06-03 | 2024-05-31 | CATX | Hunt Jonathan Robert | CFO | P - Purchase | $1.40 | +25.0K | 341.7K | +8% | +$35.0K |
| 2024-06-03 | 2024-05-31 | CATX | Williamson Robert F III | Dir | P - Purchase | $1.38 | +55.0K | 423.8K | +15% | +$75.9K | |
| M | 2024-05-30 | 2024-05-29 | CATX | Williamson Robert F III | Dir | P - Purchase | $1.33 | +30.0K | 368.8K | +9% | +$40.0K |
| D | 2024-04-24 | 2024-04-23 | CATX | Austin Mark John | VP Fin, Prin Fin, Acct Offic | M - OptEx | $0.36 | +30.0K | 84.0K | +56% | +$10.8K |
| T | 2024-03-08 | 2024-03-06 | CATX | Lantheus Alpha Therapy, LLC | 10% | P - Purchase | $0.95 | +60.43M | 116.77M | +107% | +$57.41M |
| M | 2024-02-01 | 2024-01-30 | CATX | Williamson Robert F III | Dir | P - Purchase | $0.7131 | +127.2K | 338.8K | +60% | +$90.7K |
| M | 2024-01-30 | 2024-01-26+ | CATX | Williamson Robert F III | Dir | P - Purchase | $0.5775 | +135.9K | 102.8K | New | +$78.5K |
| M | 2024-01-26 | 2024-01-24+ | CATX | Williamson Robert F III | Dir | P - Purchase | $0.49 | +52.0K | 53.5K | +3,363% | +$25.5K |
| 2024-01-26 | 2024-01-24 | CATX | Puhlmann Markus | Chief Medical Off | P - Purchase | $0.5 | +280.0K | 1.38M | +26% | +$140.0K | |
| I | 2023-12-26 | 2023-12-21 | CATX | Williamson Robert F III | Dir | P - Purchase | $0.33 | +3,663 | 3,663 | New | +$1,209 |
| M | 2023-12-19 | 2023-12-18+ | CATX | Williamson Robert F III | Dir | P - Purchase | $0.2947 | +23.7K | 10.0K | New | +$6,978 |
| M | 2023-12-19 | 2023-12-15+ | CATX | Puhlmann Markus | Chief Medical Off | P - Purchase | $0.316 | +595.4K | 635.0K | +1,504% | +$188.2K |
| 2023-12-19 | 2023-12-18 | CATX | Hunt Jonathan Robert | CFO | P - Purchase | $0.26 | +125.0K | 316.7K | +65% | +$32.5K | |
| MI | 2023-12-18 | 2023-12-14+ | CATX | Woods Lori A | Dir | P - Purchase | $0.27 | +185.2K | 1.37M | +16% | +$50.0K |
| DMI | 2023-04-19 | 2023-04-13+ | CATX | Woods Lori A | Dir | M - OptEx | $0.61 | +187.5K | 1.33M | +16% | +$114.4K |
| M | 2022-12-05 | 2022-12-01+ | CATX | Hunt Jonathan Robert | CFO | P - Purchase | $0.38 | +85.4K | 159.5K | +115% | +$32.5K |
| I | 2022-11-17 | 2022-11-15 | CATX | Woods Lori A | CEO, Dir | P - Purchase | $0.34 | +100.0K | 1.15M | +10% | +$34.0K |
| DA | 2022-09-22 | 2022-08-18 | CATX | Streeter Jennifer | COO, VP of HR | M - OptEx | $0.43 | +50.0K | 77.9K | +179% | +$21.5K |
| D | 2022-08-19 | 2022-08-18 | CATX | Streeter Jennifer | COO, VP of HR | M - OptEx | $0.43 | +50.0K | 87.9K | +132% | +$21.5K |
| D | 2022-08-10 | 2022-08-05 | CATX | Streeter Jennifer | COO, VP of HR | M - OptEx | $0.33 | +22.5K | 27.9K | +414% | +$7,425 |
| I | 2022-06-09 | 2022-06-07 | CATX | Woods Lori A | CEO, Dir | P - Purchase | $0.3 | +75.0K | 1.05M | +8% | +$22.5K |
| M | 2022-06-09 | 2022-06-08+ | CATX | Austin Mark John | VP Fin, Prin Fin, Acct Offic | P - Purchase | $0.29 | +18.8K | 54.0K | +53% | +$5,452 |
| M | 2022-06-09 | 2022-06-07+ | CATX | Hunt Jonathan Robert | CFO | P - Purchase | $0.2866 | +39.0K | 80.6K | +94% | +$11.2K |
| DMI | 2021-11-24 | 2021-11-23 | CATX | Woods Lori A | CEO, Dir | M - OptEx | $0.445 | +125.0K | 972.0K | +15% | +$55.6K |
Purchase Sale Sale after option exercise All abbreviations